These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24165911)

  • 21. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN; Tuomilehto J; Hamann A; Kallend D; Smith K
    Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
    Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
    Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.
    Weinstein DL; Williams LA; Carlson DM; Kelly MT; Burns KM; Setze CM; Lele A; Stolzenbach JC
    Clin Ther; 2013 Aug; 35(8):1186-98. PubMed ID: 23891363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Is it possible to prevent acute kidney injury in the patients who underwent contrast medium?".
    Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
    Angiology; 2014 Mar; 65(3):225-6. PubMed ID: 23564021
    [No Abstract]   [Full Text] [Related]  

  • 26. Statins and Incidence of Contrast-Induced Acute Kidney Injury Following Coronary Angiography - Five Year Experience at a Tertiary Care Center.
    Sreenivasan J; Khan MS; Li H; Zhuo M; Patel A; Fugar S; Tarbutton M; Siddamsetti S; Yadav N
    Cardiovasc Revasc Med; 2019 Aug; 20(8):654-658. PubMed ID: 30318173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comment from the cardiologic viewpoint].
    Lüscher TF
    Praxis (Bern 1994); 2009 Feb; 98(3):129-30. PubMed ID: 19180438
    [No Abstract]   [Full Text] [Related]  

  • 28. The stain wars.
    Olsson GO; Blasetto JW; Bryzinski BS; Caplan RJ; Gold A
    Lancet; 2003 Nov; 362(9398):1855-6; discussion 1856. PubMed ID: 14654329
    [No Abstract]   [Full Text] [Related]  

  • 29. Plaque-stabilizing statin therapy prior to percutaneous transluminal angioplasty and stenting.
    Spiegel R
    Circ J; 2012; 76(6):1535; author reply 1536. PubMed ID: 22453007
    [No Abstract]   [Full Text] [Related]  

  • 30. Is hsCRP Back on Board? Implications from the JUPITER Trial.
    Koenig W
    Clin Chem; 2009 Feb; 55(2):216-8. PubMed ID: 19074517
    [No Abstract]   [Full Text] [Related]  

  • 31. [Statins in primary prophylaxis of cardiovascular diseases].
    Kobalava ZhD; Villeval'de SV
    Ter Arkh; 2011; 83(9):70-5. PubMed ID: 22145392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.
    Vergès B; Florentin E; Baillot-Rudoni S; Petit JM; Brindisi MC; Pais de Barros JP; Lagrost L; Gambert P; Duvillard L
    J Lipid Res; 2009 Jun; 50(6):1209-15. PubMed ID: 19168444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
    Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.
    Albert MA; Glynn RJ; Fonseca FA; Lorenzatti AJ; Ferdinand KC; MacFadyen JG; Ridker PM
    Am Heart J; 2011 Jul; 162(1):106-14.e2. PubMed ID: 21742096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study).
    Betteridge DJ; Gibson JM; Sager PT
    Am J Cardiol; 2007 Oct; 100(8):1245-8. PubMed ID: 17920365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
    Meek C; Wierzbicki AS; Jewkes C; Twomey PJ; Crook MA; Jones A; Viljoen A
    Curr Med Res Opin; 2012 Mar; 28(3):371-8. PubMed ID: 22256801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-procedural use of statins for all patients undergoing percutaneous coronary intervention.
    Cay S
    Int J Cardiol; 2011 Jan; 146(1):103-4. PubMed ID: 20947191
    [No Abstract]   [Full Text] [Related]  

  • 39. Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. -Evaluation using dual-source computed tomography.-.
    Soeda T; Uemura S; Okayama S; Kawakami R; Sugawara Y; Nakagawa H; Matsumoto T; Sung JH; Nishida T; Senoo A; Somekawa S; Takeda Y; Ishigami K; Kawata H; Horii M; Saito Y
    Circ J; 2011; 75(11):2621-7. PubMed ID: 21821963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.
    Luo J; Li J; Shen X; Hu X; Fang Z; Lv X; Zhou S
    Int J Cardiol; 2013 Sep; 167(5):2350-3. PubMed ID: 23194788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.